Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mulberry Twig Alkaloid Tablets in Type 2 Diabetes With High Cardiovascular Risk
ChiCTR2500104382Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Guangxi University of Chinese Medicine
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ramulus mori alkaloids in type 2 diabetes mellitus (T2DM) and cardiac morbidity (2 arms), sponsored by First Affiliated Hospital of Guangxi University of Chinese Medicine. Primary endpoints: Hemoglobin A1c, Fasting blood glucose and 7 more. Started Jun 2025; status: recruiting.
02
Drugs
ramulus mori alkaloids
03
Conditions
type 2 diabetes mellitus (T2DM)cardiac morbidity
Beyond the preview
Go deeper on ChiCTR2500104382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104382.